# Contact Tesa Direct: Editorial Queries on the Tesamorelin Digest

> Contact Tesa Direct with editorial and citation queries about the tesamorelin research digest. An independent editorial project, not a clinic or vendor. No medical advice and no product sales.

Editorial corrections, citation questions, and source suggestions for the tesamorelin digest — handled in writing.

## What we can help with

Tesa Direct is an editorial project, so the contact channel is for editorial matters: a correction to a cited figure, a question about how a study was summarized, a pointer to a peer-reviewed source we have missed, or a note about the approved-vs-off-label framing. If a number on this site does not match its source, tell us and we will fix it.

We cannot answer personal medical questions, recommend doses, or advise on whether anyone should use tesamorelin. Those questions belong with a qualified healthcare professional who can account for an individual's history. We also do not sell, supply, source, or route anyone to any product, and we cannot help with obtaining tesamorelin.

## Send a message

Use the form below for editorial and citation queries. Include the page and the specific claim or reference you are writing about so we can locate it quickly. Messages are reviewed and answered in writing; there is no phone line and no clinic behind this site. Please do not send personal health information — this is an editorial inbox, not a clinical one.

---

Tesa Direct reads the tesamorelin record as a status board — the lone HIV-lipodystrophy indication held in the approved column, every other use kept in the off-label one, and each visceral-fat and IGF-1 figure carried straight back to its trial; an editorial information panel, not a clinic, a pharmacy, or a prescription.